Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study.

Wasaburo Koizumi,Toshikazu Akiya,Atsushi Sato,Toshikazu Sakuyama,Eisaku Sasaki,Takashi Tomidokoro,Tsutomu Hamada,Mototsugu Fujimori,Yoshinori Kikuchi,Ken Shimada,Tetsuya Mine,Kensei Yamaguchi,T. Sasaki,Minoru Kurihara

Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study.

2010

Wasaburo Koizumi
Toshikazu Akiya
Atsushi Sato
Toshikazu Sakuyama
Eisaku Sasaki
Takashi Tomidokoro
Tsutomu Hamada
Mototsugu Fujimori
Yoshinori Kikuchi
Ken Shimada
Tetsuya Mine
Kensei Yamaguchi
T. Sasaki
Minoru Kurihara

Purpose This prospective multicenter phase II study was carried out to investigate the efficacy, safety and pharmacokinetics of S-1 monotherapy in elderly patients over 75 years of age, with unresectable advanced or recurrent gastric cancer.

Keywords:

Recurrent gastric cancer
Stomach cancer
Phases of clinical research
Cancer
Progression-free survival
INDUCTION TREATMENT
Oncology
Body surface area
Internal medicine
Medicine
Adverse effect
first line treatment
group study
advanced gastric cancer
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations